Early Cardiac Changes During Chemotherapy in Breast Cancer

Not Applicable

Completed

• Conditions: Chemotherapy induced Cardiomyopathy; Breast Cancer; Cardiovascular - Other cardiovascular diseases; Cancer - Breast

• Registration Number: ACTRN12611000153910
• Lead Sponsor: Professor Joseph Selvanayagam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-02-09
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 100

Inclusion Criteria

All patients with new diagnosis of HER2 positive early breast cancer planned for standard chemotherapy with anthracyclines and/or trastuzumab, or, patients with recurrent breast cancer planned for chemotherapy with anthracyclines and/or trastuzumab that have not had chemotherapy in the last 5 years.

Exclusion Criteria

Patients with recurrent breast cancer that have received chemotherapy in the last 5 years, patients that don't meet safety requirements for cardiac MRI.

Study & Design

• Study Type: Observational
• Study Design: Not specified